A study has found that, OTC (Over-the-counter) Mouthwash or an ordinary breath freshener can kill coronavirus COVID-19 in just 30 seconds of contact.
Scientists at Cardiff University found that rinsing with mouthwash that contains minimum 0.07 percent of cetylpyridinium chloride (CPC) displayed the “promising signs” of lowering spread of the virus.
Their initial report, which is yet to be examined, endorses a study published last week that observed mouthwash that contains CPC, helps in decreasing the viral capacity of people affected with the coronavirus.
It comes in advance of a clinical examination on patients at the University Hospital of Wales in Cardiff to discover whether mouthwash is able to reduce coronavirus in a person’s saliva. The results are expected to be announced in early 2021.
Dentyl is the only UK mouthwash brand that is part of the clinical trial headed by Professor David Thomas of Cardiff University.
“While this in-vitro study is incredibly encouraging and is an encouraging step, more clinical research is now obviously needed,” Dr Thomas told the PA news agency, as quoted by the Independent newspaper.
“We need to understand if the effect of OTC(over-the-counter) mouthwashes on the COVID-19 virus accomplished in the laboratory can be repeated in patients, and we look forward to concluding our clinical trial in early 2021.”
Dr Nick Claydon, a professional periodontologist, said he assumed mouthwash can become a valuable addition to battling coronavirus along with “Social distancing, handwashing, and wearing masks, equally now and later-on in the future”.
There is promising news from the sprint for a vaccine of COVID-19, as US biotechnology organization Moderna on Monday said initial data from a continuing phase three study of its tentative vaccine showed it to be upto 94.5 % Effective .
The news supported from last week’s announcement from US drug titan Pfizer that stage three trial results for the COVID-19 vaccine it is forming with Germany’s BioNTech proved it to be more than 90-percent effective.